Trials / Completed
CompletedNCT00248079
The Medtronic RESOLUTE Clinical Trial
The Clinical Response Evaluation of the Medtronic Endeavor CR ABT-578 Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 139 (actual)
- Sponsor
- Medtronic Vascular · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the clinical safety, efficacy, and pharmacokinetics (PK) of the Endeavor Resolute Zotorolimus Eluting Coronary Stent System for the treatment of single de novo lesions in native coronary arteries with a reference vessel diameter (RVD) between 2.5 and 3.5 mm in diameter.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Coronary Artery Stenting | Initial implant of drug eluting stent (zotarolimus) |
Timeline
- Start date
- 2005-11-01
- Primary completion
- 2007-06-01
- Completion
- 2011-10-01
- First posted
- 2005-11-03
- Last updated
- 2011-10-20
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT00248079. Inclusion in this directory is not an endorsement.